GLPwatch
Trials (2167)
GLP-1 clinical trials from ClinicalTrials.gov, refreshed daily.
- Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
- Combination Therapy for Alcohol Use Disorder
- GLP Analogs for Diabetes in Wolfram Syndrome Patients
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
- The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
- Exenatide Once Weekly for Smoking Cessation
- Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
- Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
- A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
- Once Weekly GLP-1 in Persons With Spinal Cord Injury
- The Effect of a Liraglutide on IVF in Obese PCOS
- INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
- 16-week Flexible vs. 8-week Semaglutide Titration
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- A Study of IBI362 in Participants With Type 2 Diabetes
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
- Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers
- A Study of XW003 Injection in Chinese Adolescents With Obesity
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
- Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
- A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
- A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity
- A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
- Visualizing Beta Cells After Islet Transplantation
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
- GLP-1s to Enhance Lasting Optimal Weight
- A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
- Liraglutide to Improve corONary Haemodynamics During Exercise streSS
- Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
- Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
- Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
- Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
- Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
- Liraglutide and Cardio-Metabolic Risk Markers
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
- Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
- Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
- Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus